Issue Navigation
-
Editorial
-
196-200
Rapid evolution of the COVID-19 pandemic calls for a unified public health response
He N
BioScience Trends. 2021; 15(4):196-200.
DOI: 10.5582/bst.2021.01261
-
201-204
Traditional Chinese medicine for treatment of novel infectious diseases: Current status and dilemma
Qi FH, Tang W
BioScience Trends. 2021; 15(4):201-204.
DOI: 10.5582/bst.2021.01263
-
205-210
Opportunities and challenges to the use of neutralizing monoclonal antibody therapies for COVID-19
Su J, Lu HZ
BioScience Trends. 2021; 15(4):205-210.
DOI: 10.5582/bst.2021.01227
-
211-218
New progress in elucidating the relationship between cancer therapy and cardiovascular toxicity
Wu C, Lin DW, Ma F, Jiang F, Wang YS
BioScience Trends. 2021; 15(4):211-218.
DOI: 10.5582/bst.2021.01278
-
219-230
SatoK, Mano T, Niimi Y, Iwata A, Toda T, Iwatsubo T
BioScience Trends. 2021; 15(4):219-230.
DOI: 10.5582/bst.2021.01194
-
231-239
Anti-neuroinflammatory activity of Shenqi Fuzheng Injection and its main active constituents
Wang W, Zhang Z, Deng Y, Yang Z, Hou J, Long H, Lei M, Wu W
BioScience Trends. 2021; 15(4):231-239.
DOI: 10.5582/bst.2021.01140
-
240-248
Li LS, Zhou J, Xu YP, Huang ZS, Zhang N, Qiu XM, Wang L
BioScience Trends. 2021; 15(4):240-248.
DOI: 10.5582/bst.2021.01199
-
249-256
Chen P, Liu YY, Ma XC, Li QL, Zhang YF, Xiong QQ, Song TQ
BioScience Trends. 2021; 15(4):249-256.
DOI: 10.5582/bst.2021.01139
-
257-261
Sawakami T, Karako K, Song PP, Sugiura W, Kokudo N
BioScience Trends. 2021; 15(4):257-261.
DOI: 10.5582/bst.2021.01269
-
262-265
China should emphasize key issues inherent in rational medication management for the elderly
Tang Q, Wang C, Wu WH, Cao Y, Chen G, Lu J
BioScience Trends. 2021; 15(4):262-265.
DOI: 10.5582/bst.2021.01254